SEPTEMBER IS GYNECOLOGIC CANCER AWARENESS MONTH
Many women aren’t in tune with the warning signs of or risk factors for gynecologic cancers. That’s why, in an effort to raise awareness among women and healthcare providers and to encourage more screenings, earlier detection and increased support for gynecological cancer research, September has been designated Gynecologic Cancer Awareness Month.
Dr. Eva Chalas, MD,
Chief of Gynecologic Oncology and
Director of Clinical Cancer Services at Winthrop
“Cancers of the uterus, ovaries, fallopian tubes, peritoneum, vagina and vulva account for approximately 80,000 cancer diagnoses in the United States each year. Because gynecologic cancers are generally associated with good prognoses when they are detected in their early stages, they have not garnered as much attention as other illnesses. As a result, promotion of screening, early detection and research into the prevention, diagnosis and treatment of gynecologic cancers has lagged behind that of other cancers,” said Eva Chalas, MD, Chief of Gynecologic Oncology and Director of Clinical Cancer Services at Winthrop. A renowned expert on women’s cancers, Dr. Chalas diagnoses and treats even the most aggressive and metastatic forms of gynecologic cancer, and has lectured extensively at national and local conferences to raise awareness in both the public and professional sectors.
Dr. Chalas works in close collaboration with Jeannine Villella, DO, Associate Director of Gynecologic Oncology; Kent Chan, MD, Attending Physician in the Department of Obstetrics and Gynecology; Edward Jimenez, MD, Attending Physician in the Department of Obstetrics and Gynecology
# # #